期刊文献+

TP53 Arg72Pro and CCND1 A870G Polymorphisms and Esophageal Cancer Risk 被引量:1

TP53 Arg72Pro and CCND1 A870G Polymorphisms and Esophageal Cancer Risk
在线阅读 下载PDF
导出
摘要 The authors examined 184 residents from Kazakhstan to reveal an association of the CCND1 gene A870G and TP53 gene Arg72Pro polymorphisms with esophageal cancer risk. 86 of them were control group and 98 were patients with esophageal cancer. DNA samples were genotyped by direct sequencing method and TaqMan allelic discrimination method. Statistical analysis was performed using GraphPad InStatTM Software and "Case-Control Study Estimating Calculator" from TAPOTILI company. A significant association was revealed between CCND1 homozygous genotype (A870A, OR=2.654) and TP53 heterozygous (Arg72Pro, OR= 1.417) and homozygous (Pro72 Pro, OR=2.860) genotypes increased risk of esophageal cancer.
出处 《Journal of Life Sciences》 2010年第6期16-20,共5页 生命科学(英文版)
关键词 Cancer ESOPHAGEAL POLYMORPHISM CCND1 TP53. P53基因 食管癌 多态性 风险 细胞周期蛋白D1 TaqMan 哈萨克斯坦 直接测序法
  • 相关文献

参考文献14

  • 1E.M. Aksel, M.I. Davydov, The statistics of morbidity and mortality from malignant neoplasms in 2008, in: Malignant Neoplasms in Russia and CIS Countries in 2008, Russian Oncological Scientific Center named after N.N. Blokhin, Moscow, 2009. (in Russian).
  • 2J.R. Vermeijden, J.F. Bartelsman, P. Fockens, R.C. Meijer, G.N. Tytgat, Self-expanding metal stent for palliation of esophagocardial malignancies, Gastrointestinal Endoscopy 41 (1995) 58-63.
  • 3P.C. Enzinger, R.J. Mayer, Esophageal cancer, The New England Journal of Medicine 349 (2003) 2241-2252.
  • 4C.J. Sherr, D-type cyclins, Trends in Biochemical Sciences 20 (1995) 187-190.
  • 5J.A. Diehl, F. Zindy, C.J. Sherr, Inhibition of cyclin DI phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway, Genes & Development 11 (1997) 957-972.
  • 6Y. Hosokawa, A. Arnold, Mechanism of cyclin DI (CCND1, PRADI) overexpression in human cancer cells, analysis of allele-specific expression, Genes, Chromosomes and Cancer 22 (1) (1998) 66-71.
  • 7D.A. Solomon, Y. Wang, S.R. Fox, T.C. Lambeck, S. Giesting, Z. Lan, et al., Cyclin D I splice variants, Differential effects on localization, RB phosphorylation, and cellular transformation, The Journal of Biological Chemistry 278 (2003) 30339-303347.
  • 8S. Bates, K.H. Vousden, Mechanisms of p53-mediated apoptosis, Cellular and Molecular Life Sciences 55 (1999) 28-37.
  • 9Y. Miyashita, J. Reed, Tumour suppressor p53 is a direct transcriptional activator of the human Bax gene, Cell 80 (1995) 293-301.
  • 10L.B. Owen-Schaub, W. Zhang, J.C. Cusack, L.S. Angelo, S.M. Santee, T. Fujiwara, et al., Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression, Molecular Biology of the Cell 15 (1995) 3032-3040.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部